Friday, June 12, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 120 of 1,261
  1. US 11974980

    In vitro and xenograft anti-tumor activity of a halogenated-xanthene against refractory pediatric solid tumors

    Provectus Pharmatech, Inc. Β· Granted May 7, 2024 Β· Expires May 2, 2044

    granted
  2. US 11975022

    Trace element compositions, methods of making and use

    American Regent, Inc. Β· Granted May 7, 2024 Β· Expires May 2, 2044

    granted
  3. US 11979133

    Compositions of influenza hemagglutinin with heterologous epitopes and/or altered maturation cleavage sites and methods of use thereof

    CG Discovery, Inc. Β· Granted May 7, 2024 Β· Expires May 2, 2044

    granted
  4. US 11975106

    Uses of halogenated xanthenes in oncology and virology

    Provectus Pharmatech, Inc. Β· Granted May 7, 2024 Β· Expires May 2, 2044

    granted
  5. US 11975029

    Compositions and methods for inhibition of lineage specific proteins

    Vor Biopharma Inc. Β· Granted May 7, 2024 Β· Expires May 2, 2044

    granted
  6. US 11976109

    Neutralizing antibodies to ebola virus glycoprotein and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted May 7, 2024 Β· Expires May 2, 2044

    granted
  7. CN 117980330

    Homodimeric peptides and antibodies comprising same

    PAXTRADIA MAB SCIENCE AB Β· Granted May 3, 2024 Β· Expires Apr 28, 2044

    granted
  8. US 11971410

    Methods of classifying response to immunotherapy for cancer

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Apr 30, 2024 Β· Expires Apr 25, 2044

    granted
  9. US 11970711

    Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

    The Regents of the University of California Β· Granted Apr 30, 2024 Β· Expires Apr 25, 2044

    granted
  10. US 11970554

    Labeled oxytocin and method of manufacture and use

    TONIX PHARMACEUTICALS HOLDING CORP Β· Granted Apr 30, 2024 Β· Expires Apr 25, 2044

    granted
  11. US 11969435

    Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors

    Corcept Therapeutics Incorporated Β· Granted Apr 30, 2024 Β· Expires Apr 25, 2044

    granted
  12. US 11970534

    Antibodies and molecules that immunospecifically bind to BTN1A1 and the therapeutic uses thereof

    The Board of Regents of the University of Texas System Β· Granted Apr 30, 2024 Β· Expires Apr 25, 2044

    granted
  13. US 11970482

    Acetal compounds and therapeutic uses thereof

    Ligand Pharmaceuticals Incorporated Β· Granted Apr 30, 2024 Β· Expires Apr 25, 2044

    granted
  14. US 11969499

    Hydrogel delivery of sting immunotherapy for treatment cancer

    The Board of Regents of the University of Texas System Β· Granted Apr 30, 2024 Β· Expires Apr 25, 2044

    granted
  15. US 11969511

    Methods and compositions for antimicrobial treatment

    The Board of Regents of the University of Texas System Β· Granted Apr 30, 2024 Β· Expires Apr 25, 2044

    granted
  16. US 11970553

    Heterotandem bicyclic peptide complex

    BicycleTx Limited Β· Granted Apr 30, 2024 Β· Expires Apr 25, 2044

    granted
  17. US 11969501

    Auris formulations for treating otic diseases and conditions

    The Regents of the University of California Β· Granted Apr 30, 2024 Β· Expires Apr 25, 2044

    granted
  18. US 11969466

    Stabilized influenza hemagglutinin stem region trimers and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Apr 30, 2024 Β· Expires Apr 25, 2044

    granted
  19. US 11970555

    Bicyclic peptide ligands specific for transferrin receptor 1 (TfR1)

    BicycleTx Limited Β· Granted Apr 30, 2024 Β· Expires Apr 25, 2044

    granted
  20. US 11969470

    Topiramate compositions and methods of making and using the same

    Regents of the University of Minnesota Β· Granted Apr 30, 2024 Β· Expires Apr 25, 2044

    granted
  21. US 11970483

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited Β· Granted Apr 30, 2024 Β· Expires Apr 25, 2044

    granted
  22. US 11970543

    Anti-CD39 antibodies and use thereof

    Arcus Biosciences, Inc. Β· Granted Apr 30, 2024 Β· Expires Apr 25, 2044

    granted
  23. US 11970457

    Metabolites of [3-(4-(2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl)-phenoxy)-propyl]-diethyl-amine

    VTV THERAPEUTICS LLC Β· Granted Apr 30, 2024 Β· Expires Apr 25, 2044

    granted
  24. US 11970523

    Long-acting oxyntomodulin hybrid peptide, preparation method therefor, and application thereof

    CHINA PHARMACEUTICAL UNIVERSITY Β· Granted Apr 30, 2024 Β· Expires Apr 25, 2044

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.